A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's diseaseIris Dotan, D. Hommes, C. Janneke van der Woude et al.|Gut|2010Cited by 56
ECCO-ESGAR Guideline for Diagnostic Assessment in Inflammatory Bowel DiseaseC. Maaser, Abdominal Radiology Es, Andreas Sturm et al.|UCL Discovery (University College London)|2018Cited by 22